Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 7, Issue 13
July 11 2023
Blood Advances Cover Image for Volume 7, Issue 13

Table of Contents

INSIDE BLOOD ADVANCES

It’s high time to turn the spotlight on HbSC disease
Olubusola Oluwole,Enrico M. Novelli
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

CLINICAL GUIDELINES

American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematología, Sociedad Peruana de Hematología, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America
Ignacio Neumann,Ariel Izcovich,Ricardo Aguilar,Guillermo León Basantes,Patricia Casais,Cecilia C. Colorio,María Cecilia Guillermo Esposito,Pedro P. García Lázaro,Jaime Pereira,Luis A. Meillon García,Suely Meireles Rezende,Juan Carlos Serrano,Mario L. Tejerina Valle,Diana Altuna,Pamela Zúñiga,Felipe Vera,Lorena Karzulovic,Holger J. Schünemann
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Zinc for infection prevention in children with sickle cell anemia: a randomized double-blind placebo-controlled trial
Clinical Trials & Observations
Ruth Namazzi,Robert Opoka,Andrea L. Conroy,Dibyadyuti Datta,Abner Tagoola,Caitlin Bond,Michael J. Goings,Moon-Suhn Ryu,Sarah E. Cusick,Nancy F. Krebs,Jeong Hoon Jang,Wanzhu Tu,Russell E. Ware,Chandy C. John
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
Clinical Trials & Observations
Amy D. Shapiro,Roshni Kulkarni,Margaret V. Ragni,Hervé Chambost,Johnny Mahlangu,Johannes Oldenburg,Beatrice Nolan,Margareth C. Ozelo,Meredith C. Foster,Annemieke Willemze,Christopher Barnowski,Nisha Jain,Bent Winding,Jennifer Dumont,Stefan Lethagen,Chris Barnes,K. John Pasi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
Clinical Trials & Observations
Esther C. W. de Boer,Marit Jalink,Laura Delvasto-Nuñez,Elisabeth M. Meulenbroek,Inge Baas,Susanne R. Janssen,Claudia C. Folman,Kyra A. Gelderman,Diana Wouters,Marije D. Engel,Masja de Haas,Marie José Kersten,Ilse Jongerius,Sacha Zeerleder,Josephine M. I. Vos
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
Clinical Trials & Observations
Kitsada Wudhikarn,Ana Alarcon Tomas,Jessica R. Flynn,Sean M. Devlin,Jamie Brower,Veronika Bachanova,Loretta J. Nastoupil,Joseph P. McGuirk,Richard T. Maziarz,Olalekan O. Oluwole,Stephen J. Schuster,David L. Porter,Michael R. Bishop,Peter A. Riedell,Miguel-Angel Perales,on behalf of the Cell Therapy Consortium
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries
Clinical Trials & Observations
Boshen Jiao,Kate M. Johnson,Scott D. Ramsey,M. A. Bender,Beth Devine,Anirban Basu
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

HEALTH SERVICES AND OUTCOMES

Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support
Alfred Ian Lee,Leah E. Masselink,Laura M. De Castro,Ariela L. Marshall,Nathan T. Connell,Georgette A. Dent,Josel Fritz,Morgan Homer,Tiffany L. Lucas,Rakhi P. Naik,Marquita Nelson,Casey L. O’Connell,Anita Rajasekhar,Robby J. Reynolds,Deva Sharma,Melody Smith,Lachelle D. Weeks,Clese E. Erikson
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence
Rory M. Shallis,Rong Wang,Amer M. Zeidan,Scott F. Huntington,Natalia Neparidze,Jessica M. Stempel,Lourdes M. Mendez,Mengyang Di,Xiaomei Ma,Nikolai A. Podoltsev
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency
Matthew L. Chase,Reed Drews,Marc S. Zumberg,Leslie R. Ellis,Erin G. Reid,Aaron T. Gerds,Alfred I. Lee,Gabriela S. Hobbs,Jonathan Berry,Jason A. Freed
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Most adults with severe HbSC disease are not treated with hydroxyurea
Global Advances
William Kwesi Ghunney,Eugenia Vicky Asare,John Benaiah Ayete-Nyampong,Samuel Antwi Oppong,Mark Rodeghier,Michael R. DeBaun,Edeghonghon Olayemi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
It’s high time to turn the spotlight on HbSC disease
Olubusola Oluwole,Enrico M. Novelli
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

HEMATOPOIESIS AND STEM CELLS

Melanocortin/MC5R axis regulates the proliferation of hematopoietic stem cells in mice after ionizing radiation injury
Naicheng Chen,Yong Quan,Mo Chen,Yukai Lu,Lijing Yang,Song Wang,Fang Chen,Yang Xu,Mingqiang Shen,Hao Zeng,Shilei Chen,Fengchao Wang,Junping Wang,Mengjia Hu
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Interplay between hereditary and acquired factors determines the neutrophil counts in older individuals
Marie-France Gagnon,Sylvie Provost,Maxine Sun,Sami Ayachi,Manuel Buscarlet,Luigina Mollica,Natasha Szuber,Marie-Pierre Dubé,Lambert Busque
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

SECTM1-based CAR T cells enriched with CD7-low/negative subsets exhibit efficacy in CD7-positive malignancies
Wenwen Wei,Haiyan Ma,Dong Yang,Bin Sun,Jie Tang,Yongjie Zhu,Xinchuan Chen,Xiaoou Huang,Jiazhuo Liu,Zhengfei Hu,Ting Liu,Liqun Zou,Xudong Zhao
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia
Falk Heidenreich,Bose Falk,Henning Baldauf,Carolin Massalski,Gesine Schäfer,Elke Rücker-Braun,Heidi Altmann,Jürgen Sauter,Ute V. Solloch,Vinzenz Lange,Friedrich Stölzel,Christoph Röllig,Jan M. Middeke,Malte von Bonin,Christian Thiede,Kerstin Schäfer-Eckart,Carsten Müller-Tidow,Stefan W. Krause,Sabrina Kraus,Martin Kaufmann,Mathias Hänel,Hubert Serve,Andreas Neubauer,Martin Bornhäuser,Alexander H. Schmidt,Johannes Schetelig
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

LYMPHOID NEOPLASIA

Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing
Natacha Azussa Migita,Patrícia Yoshioka Jotta,Natália Paiva do Nascimento,Victor Sande Vasconcelos,Gabriel Lopes Centoducatte,Katlin Brauer Massirer,Amilcar Cardoso de Azevedo,Silvia Regina Brandalise,José Andrés Yunes
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
Yazeed Sawalha,Subir Goyal,Jeffrey M. Switchenko,Jason T. Romancik,Manali Kamdar,I. Brian Greenwell,Brian T. Hess,Krista M. Isaac,Craig A. Portell,Alex Mejia Garcia,Scott Goldsmith,Natalie S. Grover,Peter A. Riedell,Reem Karmali,Madelyn Burkart,Michael Buege,Othman Akhtar,Pallawi Torka,Anita Kumar,Brian T. Hill,Brad S. Kahl,Jonathon B. Cohen
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis
Farah Mazahreh,Liyan Mazahreh,Carolina Schinke,Sharmilan Thanendrarajan,Maurizio Zangari,John D. Shaughnessy, Jr.,Fenghuang Zhan,Frits van Rhee,Samer Al Hadidi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
Clinical Trials & Observations
Mark B. Geyer,Brian C. Shaffer,Bhavana Bhatnagar,Alice S. Mims,Victoria Klein,Deepika Dilip,Jacob L. Glass,Gerard Lozanski,Hani Hassoun,Heather Landau,Yanming Zhang,Wenbin Xiao,Mikhail Roshal,Jae H. Park
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis
Shuguang Liu,Yuening Xiang,Boshi Wang,Chao Gao,Zhenping Chen,Shao Xie,Jing Wu,Yi Liu,Xiaoxi Zhao,Chao Yang,Zhixia Yue,Linya Wang,Xiaojia Wen,Ruidong Zhang,Feng Zhang,Heng Xu,Xiaowen Zhai,Huyong Zheng,Hui Zhang,Maoxiang Qian
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL
Rosalie Griffin,Julia E. Wiedmeier-Nutor,Sameer A. Parikh,Chantal E. McCabe,Daniel R. O'Brien,Nicholas J. Boddicker,Geffen Kleinstern,Kari G. Rabe,Laura Bruins,Sochilt Brown,Cecilia Bonolo de Campos,Wei Ding,Jose F. Leis,Paul J. Hampel,Timothy G. Call,Daniel L. Van Dyke,Neil E. Kay,James R. Cerhan,Huihuang Yan,Susan L. Slager,Esteban Braggio
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
Christopher J. Forlenza,Jaclyn Rosenzweig,Audrey Mauguen,Ilia Buhtoiarov,Branko Cuglievan,Hema Dave,Rebecca J. Deyell,Jamie E. Flerlage,Anna K. Franklin,Jennifer Krajewski,Kasey J. Leger,Lianna J. Marks,Robin E. Norris,Martha Pacheco,Faye Willen,Adam Paul Yan,Paul D. Harker-Murray,Lisa Giulino-Roth
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

MYELOID NEOPLASIA

A global study for acute myeloid leukemia with RARG rearrangement
Hong-Hu Zhu,Ya-Zhen Qin,Zhang-Lin Zhang,Yong-Jing Liu,Li-Jun Wen,M. James You,Cheng Zhang,Esperanza Such,Hong Luo,Hong-Jian Yuan,Hong-Sheng Zhou,Hong-Xing Liu,Reng Xu,Ji Li,Jian-Hu Li,Jian-Ping Hao,Jie Jin,Liang Yu,Jing-Ying Zhang,Li-Ping Liu,Le-Ping Zhang,Rui-Bin Huang,Shu-Hong Shen,Su-Jun Gao,Wei Wang,Xiao-Jing Yan,Xin-You Zhang,Xin Du,Xiao-Xia Chu,Yan-Fang Yu,Yi Wang,Ying-Chang Mi,Ying Lu,Zhen Cai,Zhan Su,David Christopher Taussig,Suzanne MacMahon,Edward D. Ball,Huan-You Wang,John S. Welch,C. Cameron Yin,Gautam Borthakur,Miguel A. Sanz,Hagop M. Kantarjian,Jin-Yan Huang,Jiong Hu,Su-Ning Chen
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
Clinical Trials & Observations
Stéphane de Botton,Pierre Fenaux,Karen Yee,Christian Récher,Andrew H. Wei,Pau Montesinos,David C. Taussig,Arnaud Pigneux,Thorsten Braun,Antonio Curti,Carolyn Grove,Brian A. Jonas,Asim Khwaja,Ollivier Legrand,Pierre Peterlin,Montserrat Arnan,William Blum,Daniela Cilloni,Devendra K. Hiwase,Joseph G. Jurcic,Jürgen Krauter,Xavier Thomas,Justin M. Watts,Jay Yang,Olga Polyanskaya,Julie Brevard,Jennifer Sweeney,Emma Barrett,Jorge Cortes
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
TAK-981, a SUMOylation inhibitor, suppresses AML growth immune-independently
Han Sun Kim,Bo-Reum Kim,Thien T. P. Dao,Jin-Mo Kim,Yoon-Ju Kim,Hyunsong Son,Sihyang Jo,Doyeon Kim,Jiwoo Kim,Young Ju Suh,Hee-Je Kim,Byung-Sik Cho,Sunghyouk Park
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
Francoise Levavasseur,Samia Oussous,Tuerdi Zubaidan,Olivier Kosmider,Frédéric Pendino,David Rombaut,Didier Bouscary,Michaela Fontenay,Evelyne Lauret,Isabelle Dusanter-Fourt
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity
Alexandre Bazinet,Tapan Kadia,Nicholas J. Short,Gautam Borthakur,Sa A. Wang,Wei Wang,Sanam Loghavi,Jeffrey Jorgensen,Keyur Patel,Courtney DiNardo,Naval Daver,Yesid Alvarado,Fadi G. Haddad,Sherry Pierce,Graciela Nogueras Gonzalez,Abhishek Maiti,Koji Sasaki,Musa Yilmaz,Philip Thompson,William Wierda,Guillermo Garcia-Manero,Michael Andreeff,Elias Jabbour,Marina Konopleva,Xuelin Huang,Hagop Kantarjian,Farhad Ravandi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment
Christina Schjellerup Eickhardt-Dalbøge,Anna Cäcilia Ingham,Lee O'Brien Andersen,Henrik V. Nielsen,Kurt Fuursted,Christen Rune Stensvold,Morten Kranker Larsen,Lasse Kjær,Sarah Friis Christensen,Trine Alma Knudsen,Vibe Skov,Christina Ellervik,Lars Rønn Olsen,Hans Carl Hasselbalch,Xiaohui Chen Nielsen,Jens Jørgen Elmer Christensen
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study
Rajani P. Brandsen,Roselie M. H. Diederen,Siham Bakhlakh,Erfan Nur,Reinier O. Schlingemann,Bart J. Biemond
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Gata1s mutant mice display persistent defects in the erythroid lineage
Te Ling,Kevin Zhang,Jiayue Yang,Sandeep Gurbuxani,John D. Crispino
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

THROMBOSIS AND HEMOSTASIS

Selective modulation of activated protein C activities by a nonactive site–targeting nanobody library
Derek S. Sim,Meenal Shukla,Cornell R. Mallari,José A. Fernández,Xiao Xu,Doug Schneider,Maxine Bauzon,Terry W. Hermiston,Laurent O. Mosnier
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia
Sevasti B. Koukouritaki,Aye Myat M. Thinn,Katrina J. Ashworth,Juan Fang,Haley S. Slater,Lily M. Du,Huong Thi Thu Nguyen,Xavier Pillois,Alan T. Nurden,Christopher J. Ng,Jorge Di Paola,Jieqing Zhu,David A. Wilcox
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

TRANSPLANTATION

Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies
Giancarlo Fatobene,Livia Mariano,Fernanda Volt,Frederico Moreira,Jan Conelissen,Sabine Furst,Etienne Daguindau,Anne Sirvent,Régis Peffault de Latour,Hanadi Rafii,Monica M. Rivera-Franco,Chantal Kenzey,Graziana Maria Scigliuolo,Barbara Cappelli,Annalisa Ruggeri,Eliane Gluckman,Vanderson Rocha,on behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party of the European Society for Blood and Marrow Transplantation
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RESEARCH LETTERS

Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS
Anna Stengel,Torsten Haferlach,Constance Baer,Stephan Hutter,Manja Meggendorfer,Wolfgang Kern,Claudia Haferlach
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Personalized risk model for predicting risk of acute coronary syndrome in patients with myelodysplastic syndromes
Natalie Montarello,Alasdair Leslie,Rakchha Chhetri,Oisin Friel,Deepak Singhal,David Ross,David Yeung,Chung H. Kok,Peter J. Psaltis,Devendra K. Hiwase
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS
Clinical Trials & Observations
Douglas E Gladstone,Franco D'Alessio,Christopher Howard,Mi-Ae Lyu,Jason R. Mock,Kevin W. Gibbs,Darryl Abrams,Meixian Huang,Ke Zeng,James P. Herlihy,Sergio T. Castillo,Roland Bassett,Tara Sadeghi,Simrit Parmar,Christopher R. Flowers,Siddhartha Mukherjee,David Schoenfeld,Peter F. Thall,Arthur S. Slutsky
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease
Robert M. Cronin,Chyongchiou J. Lin,ChienWei Chiang,Sarah R. MacEwan,Michael R. DeBaun,J. Madison Hyer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms
Clinical Trials & Observations
Julian Lindsay,Carla S. Walti,Anna B. Halpern,Hu Xie,E. Lisa Chung,Kelda G. Schonhoff,Emily M. Huebner,Guang-Shing Cheng,Louise E. Kimball,Wendy M. Leisenring,Matthew Greenwood,Sharon C. -A. Chen,David C. M. Kong,Monica A. Slavin,Michael Boeckh,David N. Fredricks,Catherine Liu,Steven A. Pergam,Roland B. Walter,Joshua A. Hill
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies
Mazie Tsang,Kara Bischoff,Kelly L. Schoenbeck,Kim Berry,David O’Riordan,Bita Fakhri,Sandy W. Wong,Nina Shah,Rebecca Olin,Charalambos Andreadis,Jules Vieaux,Eve Cohen,Nancy Shepard Lopez,Gabriel N. Mannis,Michael Rabow
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Challenges in applying diagnostic criteria for systemic mastocytosis
Nathan A. Boggs,Xiaoping Sun,Jonathan J. Lyons,Jeremy C. McMurray,David M. Rose,Eric M. Pryor,Dean D. Metcalfe,Irina Maric
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS
Ekin Guney,Calixto-Hope G. Lucas,Kunwar Singh,Melike Pekmezci,Sebastian Fernandez-Pol,Kanish Mirchia,Angus Toland,Hannes Vogel,Serguei Bannykh,Kristian T. Schafernak,Sanda Alexandrescu,Bret C. Mobley,Suzanne Powell,Christian J. Davidson,Janna Neltner,Daniel R. Boué,Eyas Hattab,Sean P. Ferris,Robert S. Ohgami,James L. Rubenstein,Andrew W. Bollen,Tarik Tihan,Arie Perry,David A. Solomon,Kwun Wah Wen
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

ERRATA

Ilich A, Gernsheimer TB, Triulzi DJ, et al. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. Blood Adv. 2023;7(6):900-908.
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Huynh A, Arnold DM, Michael JV, et al. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Adv. 2023;7(2):246-250.
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Nawas MT, Sanchez-Escamilla M, Devlin SM, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(22):5898-5907.
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
All Issues

Advertisement intended for health care professionals

Sickle cell care and implementation science
Humanizing CAR T-cell therapy in B-ALL
Persistent postremission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
Fedratinib in 2025 and beyond: indications and future applications

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals